📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

SOX17 Enhancer Variants Disrupt Transcription Factor Binding And Enhancer Inactivity Drives Pulmonary Hypertension. (2023)

First Author: Walters R

Attributed to: Mechanisms underlying the development of pulmonary arterial hypertension funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1161/circulationaha.122.061940

PubMed Identifier: 37066790

Publication URI: http://europepmc.org/abstract/MED/37066790

Type: Journal Article/Review

Volume: 147

Parent Publication: Circulation

Issue: 21

ISSN: 0009-7322